- Location: Montreux, Switzerland
- Dates: Wednesday 19th September to Friday 21st September 2018
- Price: €
Registered participants can now take advantage of the online partnering system available during this event. The online partnering system enables participants to contact and arrange appointments with all other registered participants at the event, with time for two partnering sessions forming part of the overall programme. Participants can access this system at Online Partnering System, using the username and password supplied by email.
We are delighted that Nigel Sheail, Global Head, Mergers & Acquisitions and Business Development & Licensing, Novartis, will deliver the keynote presentation to open the XIV IPLS on 20th September. Details of all speakers participating at the event can be found here; Full Speaker Details.
The XIV IPLS that will take place in the stunning surroundings of Montreux, Switzerland, starting in the afternoon of Wednesday 19th to Friday 21st September 2018. The event begins on 19th September with the opportunity to hold pre-arranged partnering meetings (an online partnering system is available to contact all participants and make appointments) prior to the evening networking reception held in Funky Claude’s Jazz Bar.
Montreux is a beautiful one hour and ten minute train journey direct from Geneva Airport, with fantastic scenery as the train skirts around the edge of Lake Geneva.
Participants now have the option of joining one of two additional training workshops being run in parallel to the one-to-one meeting time on Wednesday from 3pm-6pm. The 3-hour training workshops can be booked online at a cost of €100 per person, and will cover:
Workshop A – Financial Evaluation of Licensing Deals
Workshop B – Alliance Management
Train tickets for journeys direct from Geneva Airport to Monteux should be purchased in advance from the SBB website, www.sbb.ch/en, to take advantage of low ticket prices from CHF18 per journey.
Following the success of the online partnering system used during the 2017 event in Madrid, the programme will once again commence on Wednesday afternoon for pre-arranged one-to-one meetings prior the evening drinks reception overlooking Lake Geneva. Partnering and networking will be ongoing throughout the event, with a managed and dedicated one-to-one meeting room available, with extended breaks and a gala dinner on Thursday evening.
The programme will feature 5 sessions, including Deal Case Studies from across the industry (Medical Devices, Biotech, Big Pharma), Regulatory Updates, Opportunities and Market Entry in China, plus the regular look at the Deal Landscape including views and analysis from Evaluate.
Nicholas Hall Group of Companies
F. Hoffmann-La Roche
|3pm - 6pm||Pre-Arranged One-to-One Meetings|
|3pm-6pm||Optional Training Workshops (additional €100 per person)
|Workshop A||Financial Evaluation of Licensing Deals
|Workshop B||Alliance Management
ANTHONY A. HOERNING
Strategic Transactions Advisory
|6pm - 8pm||Welcome Networking Reception - Funky Claude's Bar (at Fairmont Le Montreux Palace)|
|9am - 9.30am||Registration|
|Session A||NEW OPPORTUNITIES FOR BD IN A CHANGING WORLD|
|9.30am - 10am||Global Innovation - Opening New Frontiers for BD&L Activities
Global Head, Mergers & Acquisitions and Business Development & Licensing, Novartis
|10am-10.30am||Brexit and its Consequences for the Pharmaceutical Industry
Managing Director Scientific Affairs, B.A.H. (German Medicines Manufacturers' Association)
|10.30am - 11am||Business Opportunities Opening in China
Managing Director and Partner, Head of China Practice, L.E.K. Consulting
|11am 11.30am||Market Entry in China
RONG HUI GAO
Business Development & Licensing, Merger & Acquisitions, Managing Director, G-Med Consulting Ltd
|11.30am - 12pm||BREAK|
|SESSION B||NEWS FROM THE REGULATORY & MARKET ACCESS ENVIRONMENT AND THEIR IMPACT ON BD|
|12pm -12.30pm||Market Access Challenges
Head Market Access, Helsinn Healthcare Switzerland
|12.30pm - 1pm||Regulatory Updates on Current Changes and Impact on BD
Associate, Covington & Burling
|1pm - 2pm||LUNCH|
|SESSION C||LESSONS FROM REAL WORLD CASE STUDIES|
|2pm - 2.30pm||Food Supplements
President, FederSalus (Italy)
|2.30pm-3pm||Biotech and Big Pharma Deals
Global Head of Licensing, Servier Monde
|3pm - 3.30pm||Enoxaparin Biosimilars in Germany - A Case Study
Senior Advisor Pharma, Biotech, MedTech and Diagnostics
|3.30pm - 4pm||Looking Back at the Top Deals - Which Were Truly Successful
ELENA COLUCCELLI-GUERIN Managing Director, Investment Banking, Healthcare, BNP Paribas
Pharma Analyst, Exane BNP Paribas
|4pm - 6pm||Pre-Arranged One-to-One Meetings|
|7pm - 10pm||Networking Reception and Gala Dinner|
|SESSION D||ANALYSING THE HOTTEST DEAL EVOLUTIONS AND NEW DYNAMICS|
|9am - 9.30am||Pharma’s Growth Trajectory: Is It Sustainable?
Head of Custom Solutions, Evaluate
|9.30am - 10am||Current Key Deal Making Trends in Oncology
Managing Director Life Science, Navigant
|10am - 10.30am||Joint Development Agreements and Creative Deal Structures
Global Head of Transactions, Roche Partnering
|10.30am - 11am||BREAK|
|SESSION E||BACK TO THE FUTURE: HOW CAN WE BUILD A FUTURE WITHOUT LOSING OUR PAST?|
|11am - 11.30am||Designing the Optimal Exit Strategy: IPO, M&A or Dual Track? Featuring Case Studies from Leading Biotech Players in Benelux: Argenx, Galapagos, Ablynx & Ogeda
Executive Director, Corporate Finance, Life Sciences & Healthcare, Kempen
|11.30am - 12pm||Transformational Deals - Deals Which Changed the Business
Head of Biosimilars, Mundipharma International
|12pm - 12.30pm||Pharma Deals: Which Trends are Driving the Future of Deal Making?
Vice President, European Thought Leadership, IQVIA
|12.30pm - 2pm||LUNCH AND CLOSE|
Fairmont Le Montreux Palace
Avenue Claude Nobs 2
A discounted rate of CHF299 bed & breakfast, per night, is available at the Fairmont Le Montreux Palace for all attendees. This rate can be booked directly with the hotel using the link below. These rates are for Weds 19th – Fri 21st September. For any additional nights or further information please contact firstname.lastname@example.org